Literature DB >> 3881904

Calcium antagonists for acute ischemic heart disease.

M D Winniford, J T Willerson, L D Hillis.   

Abstract

The pharmacologic and physiologic effects of the slow-channel calcium antagonists verapamil, nifedipine and diltiazem are reviewed. Relevant pathophysiologic features of various acute ischemic heart disease syndromes are also reviewed and the clinical applications of the slow-channel calcium antagonists to acute ischemic heart disease syndromes in patients are discussed.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3881904     DOI： 10.1016/0002-9149(85)90620-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  2 in total

1.  [Anti-ischemic effect of verapamil within the scope of interventional recanalization].

Authors:  O Oldenburg; D Baumgart; J Schaar; H Eggebrecht; G Caspari; M Haude; R Erbel
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

2.  Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.

Authors:  F T van Amsterdam; M S van Amsterdam-Magnoni; M Haas; N C Punt; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.